Update

Clinical Computing PLC
10 October 2002


10 October 2002

                             CLINICAL COMPUTING PLC

                                    Update

Ahead of meetings with institutional shareholders, Clinical Computing Plc, the
international developer of clinical information systems for the healthcare
market, issued the following statement with respect to its latest version of
Clinical Vision.

'We are pleased to report that the latest version of our software product
Clinical Vision, version 4.0 is now being installed at the first three customer
sites, which are scheduled to go live in the coming months. Inclusive of the
three current installations, we presently have a backlog of six orders for
Clinical Vision 4.0 in excess of £800,000. Our sales prospects for both the
renal and transplant application continue to improve. We believe that once we
are in a position to demonstrate the advanced functionality of Clinical Vision
4.0 at live sites further sales will follow.

The first users of the Clinical Vision 4.0 will be deploying the renal
application; and we also expect to deploy the liver transplantation application
this year with our first live transplant site under Clinical Vision 4.0 ready in
early 2003.

We believe that in the United Kingdom, Australia/Asia and the United States the
replacement of clinical healthcare systems will continue to gain priority as,
over time, health organisations will demand more advanced functionality from the
systems they acquire. We believe that Clinical Vision will meet the needs of
these organizations and with these sites live our sales prospects will continue
to improve.
 

ENDS

For further information, please contact:
Jack Richardson, Chief Executive,               Tel: [phone]
Clinical Computing Plc 

Joe Marlovits, Finance Director,                Tel: [phone]
Clinical Computing Plc 

Paul McManus/Peter Binns,                       Tel: [phone]
Binns & Co PR Ltd     
 

                      This information is provided by RNS
            The company news service from the London Stock Exchange